Toxic Breast Implants
French Warned of Toxic Implants, no one listened
Thousands Of Women Given Leaky, Toxic Breast Implants Complete article.
Breast Implants and Rupture Science is still debating as to whether ruptured silicone breast implants are responsible for illness and disease. What is known is that when the silicone leaches throughout the body, it wants to stay in the body. Any foreign matter, including silicone, is not easily transported out of the body. The body needs help in ridding itself of any potentially harmful agent.Posted Feb 2011
DNR, Inc. has created Body Soak-Gold for those women who have experienced ruptured silicone implants. Its design is to help activate the body's own resources necessary for it to release and remove impurities resulting from leaching or ruptured implants. This can occur with each soak and for hours thereafter.
Light Energized SolutionsBody Soak GOLD Item #: 105-G
Your Price: $52.00
Stress - Cleansing - Breast Implants - Relaxing - Emotions
Another attempt by mainstream medicine to keep women uninformed about health risks has been stymied.
In February 2011, Public Citizen alerted the FDA that the presidents of two leading plastic surgery organizations – the American Society of Plastic Surgeons (ASPS) and the American Society for Aesthetic Plastic Surgery (ASAPS) – urged members to inaccurately downplay the significance of recent evidence about the risks of breast implant-related cancer when speaking to female patients during a recent members-only webinar posted on the ASPS and ASAPS websites. Such communications represented a deplorable attempt to trivialize the significance of the findings of increased numbers of cases of a rare form of cancer, called anaplastic large cell lymphoma (ALCL), in women with breast implants. Public Citizen called on the FDA to stop this deliberately misleading messaging campaign, the goal of which apparently was to keep women in the dark about the dangers of breast implants so they will continue to ask for them. Complete article
New Leadership: Karuna R. Jaggar appointed Executive Director of Breast Cancer Action.
San Francisco, CA— After an exhaustive search the Breast Cancer Action board of directors announced Karuna R. Jaggar as the organization’s new executive director. “We feel extremely proud and excited about our new Executive Director,” said BCA board president Claudia Cappio. “Karuna has worked in non-profit leadership and capacity building for 15 years advocating for women’s rights and socio-economic empowerment. She uncompromisingly challenges inequities at every level and this will continue to be her focus as she leads Breast Cancer Action.”
Jaggar has a personal passion to end the breast cancer epidemic fueled by her commitment to social justice and her own experiences as a patient advocate. “My closest family members have grappled with three breast cancer diagnoses during the last ten years,” Jaggar stated. “It is not enough to educate ourselves and try to make “good” lifestyle choices. We need systemic change to end this breast cancer epidemic.”
Jaggar is driven by the reality that social injustices and environmental factors put each of us at risk of developing breast cancer, regardless of family medical history. “Every woman affected by breast cancer should possess the power and knowledge to make informed decisions that enable them to take control of their healthcare,” Jaggar said. “This includes a women’s right to access affordable treatment options, to create individualized treatment plans, and to make healthcare decisions centered on personal values and priorities.”
Under Jaggar’s leadership, BCA will remain uncompromising on issues of health, social and environmental justice: “We will continue to fearlessly and relentlessly tell the truth about breast cancer,” Jaggar asserted.
Breast Cancer Action, the San Francisco based national watchdog of the breast cancer movement, is known for a commitment to understanding breast cancer through a social justice and health equity lens. The organization demands greater corporate accountability and better treatment options for patients; pays keen attention to the social inequities that cause differences in breast cancer incidence and outcomes; secures changes at the policy level to reverse involuntary exposure to carcinogens; and works to shift the balance of power at the FDA away from pharmaceutical companies towards patient interests.
Prior to her role at BCA, Jaggar was the Executive Director, East Bay of the Women’s Initiative for Self Employment where she worked to reverse inequities among low-income women and women of color. Jaggar replaces Barbara Brenner who retired at the end of 2010.